Background: Frontotemporal dementia (FTD) remains one of the most common forms of early-onset dementia (45 to 65 years). FTD consists clinically and pathologically of a heterogeneous group of disorders characterized by progressive frontal and temporal lobe atrophy. Thirty to fifty percent of cases have a family history of the disease. In this work we aimed to characterize pathogenic variants implicated in familial FTD cases in a cohort from Argentina.
Method: A total of 43 patients (23 women, 20 men) meeting clinical criteria for probable behavioral variant-FTD, semantic or nonfluent primary progressive aphasia, according to the Rascovsky and Gorno-Tempini criteria, were evaluated at a memory clinic in Buenos Aires, Argentina. Genomic DNA was obtained from peripheral blood leukocytes for all patients using standard protocols. C9ORF72 hexanucleotide repeat expansion (C9-HRE) was assessed by repeat-primed PCR. Whole exome sequencing and bioinformatic analysis of FTD-causative genes was performed on C9-HRE negative cases.
Result: 29 out of 43 patients (67%) were familial cases, of which 3 were C9-HRE positive (10.3%). Eleven familial cases who were C9-HRE negative were studied by exome sequencing. We found previously reported pathogenic variants in 2 cases [GRN (NM_002087.4): c.1216C>T: p.Gln406Ter and GRN (NM_002087.4): c.709-1G>A: p.?], respectively. Also, we found two variants of unknown significance in other two probands [PDE11A (NM_016953.4): c.2518G>A: p.Glu840Lys; PSEN2 (NM_000447.3): c.800T>G: p.Val267Gly], respectively.
Conclusion: Here we report the genetic screening of familial FTD cases from a memory clinic in Argentina. C9-HRE is still the most common cause of familial FTD. Further studies are warranted on the role of the PSEN2 and PDE11A variants found in two probands. This work adds to the knowledge of the genetic landscape of FTD in our country.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/alz.085944 | DOI Listing |
Alzheimers Dement
December 2024
Penn FTD Center, University of Pennsylvania, Philadelphia, PA, USA.
Background: Previously, the Penn Frontotemporal Degeneration (FTD) Center developed and validated criteria to stratify pedigrees of patients with FTD by likelihood of identifying a genetic etiology (Wood, JAMA Neurol., 2013). Pedigrees were classified as high-risk, medium-risk, low-risk, apparent sporadic, or unknown significance.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Delaware State University, Dover, DE, USA.
Background: Aggregation of transactive response DNA binding protein 43 (TDP-43) is the major pathological feature of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Recently, in up to 50% of Alzheimer's disease (AD) cases TDP-43 pathology was discovered and this pathology has been referred to as limbic-predominant age-related TDP43 encephalopathy (LATE). Several studies reported that TDP-43 binds to heat shock protein family B (small) member 1 (HSPB1 or HSP27) but no functional evaluation of this interaction has been explored.
View Article and Find Full Text PDFBackground: Frontotemporal dementia (FTD) remains one of the most common forms of early-onset dementia (45 to 65 years). FTD consists clinically and pathologically of a heterogeneous group of disorders characterized by progressive frontal and temporal lobe atrophy. Thirty to fifty percent of cases have a family history of the disease.
View Article and Find Full Text PDFBackground: Frontotemporal dementia is the most common form of dementia impacting those under the age of 60. It is estimated that 30% of affected persons have a genetic predisposition to this disease, with mutations in the genes encoding progranulin (GRN), chromosome 9 open reading frame 72(C9orf72), and microtubule associated protein tau (MAPT). Mutations in MAPT were discovered in 1998, yet to date, there have been no therapies or multisite clinical trials available to families.
View Article and Find Full Text PDFDementia was a condition I was aware of from a very young age as I witnessed my grandmother decline, and my mother step into the role as a caregiver, health care director and power of attorney. I was taught the foundation for this process by direct observation of my mother's actions. One aspect of caregiving that isn't teachable is the emotional pain, anguish, sadness and guilt that often accompanies that role.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!